Bailly P, Piller F, Cartron J P
Laboratoire de Biochimie Génétique, Institut National de Transfusion Sanguine, Paris, France.
Eur J Biochem. 1988 Apr 15;173(2):417-22. doi: 10.1111/j.1432-1033.1988.tb14015.x.
Two galactosyltransferases identified as UDP-galactose:lactose (lactosylceramide) alpha-4- and beta-3-galactosyltransferases [Bailly P. et al. (1986) Biochem. Biophys. Res. Commun. 141, 84-91] have been characterized in human kidney microsomes. Using methyl beta-D-galactoside as acceptor substrate, we have determined the experimental conditions (pH 5.0, 4 mM Cd2+) in which only the beta-3-galactosyltransferase activity is detectable. The reaction product has been characterized by chemical methods and glycosidase studies. Under these experimental conditions, some of the enzyme properties have been further investigated. Apparent Km values are for UDP-galactose, 0.170 mM; for lactose, 242 mM; and for lactosylceramide, 2.5 mM. Acceptor specificity studies suggest that the beta-3-galactosyltransferase is specific for terminal Gal beta 1-4Glc(NAc) residues and responsible for elongation of oligosaccharide chains in glycolipids. Competition studies with lactose and N-acetylgalactosamine as acceptor substrates indicate that the transferase described here can be distinguished from the UDP-galactose:2-acetamide-2-deoxy-D-galactose beta-3-galactosyltransferase and therefore represents a novel enzyme capable of synthesizing unusual carbohydrate structures similar to those which accumulate in certain neurological diseases.
已在人肾微粒体中鉴定出两种半乳糖基转移酶,分别为UDP-半乳糖:乳糖(乳糖基神经酰胺)α-4-和β-3-半乳糖基转移酶[贝利·P.等人(1986年)《生物化学与生物物理研究通讯》141卷,84 - 91页]。以β-D-甲基半乳糖苷作为受体底物,我们确定了仅能检测到β-3-半乳糖基转移酶活性的实验条件(pH 5.0,4 mM Cd2+)。通过化学方法和糖苷酶研究对反应产物进行了表征。在这些实验条件下,对该酶的一些性质进行了进一步研究。表观Km值分别为:对于UDP-半乳糖,0.170 mM;对于乳糖,242 mM;对于乳糖基神经酰胺,2.5 mM。受体特异性研究表明,β-3-半乳糖基转移酶对末端Galβ1-4Glc(NAc)残基具有特异性,负责糖脂中寡糖链的延长。以乳糖和N-乙酰半乳糖胺作为受体底物的竞争研究表明,此处描述的转移酶可与UDP-半乳糖:2-乙酰胺-2-脱氧-D-半乳糖β-3-半乳糖基转移酶区分开来,因此代表了一种新型酶,能够合成与某些神经疾病中积累的碳水化合物结构类似的异常碳水化合物结构。